Sep 2026· DEN Open· Vol 7· 0 citations· 28 references
Medicine
TL;DR
Of the two partially covered MSs evaluated, the EGIS biliary stent demonstrated fewer early non‐RBO AEs after EUS‐HGS, and the EGIS biliary stent demonstrated fewer early non‐RBO AEs after EUS‐HGS.
Abstract
ABSTRACT Objectives Endoscopic ultrasound‐guided hepaticogastrostomy (EUS‐HGS) is an alternative biliary drainage method after failed endoscopic retrograde cholangiopancreatography. Nevertheless, it is associated with adverse events (AEs), including peritonitis and stent migration. The influence of metallic stent (MS) design characteristics, including axial force (AF), on the safety and efficacy of EUS‐HGS remains unclear. Methods This multicenter retrospective study included patients with unresectable malignant biliary obstruction who underwent EUS‐HGS using either a high‐AF MS (Niti‐S biliary S‐type) or a low‐AF MS (EGIS biliary) between January 2019 and December 2022. Propensity score matching was performed in a 1:2 ratio. Outcomes included clinical success, early and late non‐recurrent biliary obstruction (non‐RBO) AEs, RBO, time to RBO (TRBO), and overall survival (OS). Results After matching, 27 patients in the high‐AF group and 54 in the low‐AF group were analyzed. Clinical success, RBO rate, TRBO, OS, and late non‐RBO AE rates were similar between groups. However, early non‐RBO AEs were more frequent in the high‐AF group (37% vs. 13%, p = 0.02). Conclusions Of the two partially covered MSs evaluated, the EGIS biliary stent demonstrated fewer early non‐RBO AEs after EUS‐HGS.
Metal stents showed longer TRBO, lower recurrent biliary obstruction rate, and higher adverse event rate than plastic stents during EUS-HGS, according to a systematic meta-analysis.
Hirofumi Yamazaki, M. Itonaga, K. Wan et al.· Digestive Endoscopy· 0 citations
ABSTRACT Objectives The clinical performance of double half‐pigtail plastic stents (DHPs) for malignant distal biliary obstruction (MDBO) remains unclear. We compared DHPs with straight plastic stents (STs) regarding the timing, incidence, and causes of recurrent biliary obstruction (RBO). Methods This single‐center re...
Wataru Yoshioka, Mutsumi Tasaki, Hinata Tasaki et al.· DEN Open· 0 citations
OBJECTIVES
Self-expandable metallic stents (SEMS) are commonly used to treat biliary obstruction in patients with unresectable pancreatic cancer. Fully covered SEMS (FCSEMS) prevents tumor ingrowth but is prone to migration. Multi-hole SEMS (MHSEMS) has multiple holes in the stent membrane, prevents stent migration. Th...
Takashi Ito, T. Ikeura, Ayaka Orino et al.· Pancreas· 0 citations
ABSTRACT Background and Aims Inside stents are increasingly used for malignant hilar biliary obstruction because of their prolonged patency and removability. Although reported migration rates vary, migration remains a clinical concern, and deployment in angulated bile ducts can be technically challenging. We evaluated...
Motoyasu Kan, Daiki Takahashi, Sodai Uchida et al.· DEN Open· 0 citations
Background/Aims
Although endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) has been reported to have favorable outcomes, it is associated with a risk of severe adverse events. Despite the increasing frequency of EUS-HGS use in older patients, its safety and efficacy in this population have not been sufficientl...